EP 0812355 A2 19971217 - AGENT FOR TREATING TUMOURS AND OTHER HYPERPLASIA
Title (en)
AGENT FOR TREATING TUMOURS AND OTHER HYPERPLASIA
Title (de)
MITTEL ZUR THERAPIE VON TUMOREN UND ANDEREN HYPERPLASIEN
Title (fr)
AGENT UTILISE DANS LE TRAITEMENT DE TUMEURS ET D'AUTRES HYPERPLASIES
Publication
Application
Priority
- DE 9600351 W 19960226
- DE 19508734 A 19950228
- DE 19539130 A 19951020
Abstract (en)
[origin: WO9627008A2] The invention concerns an agent for treating tumours and other hyperplasia. Areas of application of the invention include medicine and the pharmaceutical industry. The agent according to the invention is characterized in that it comprises: a tumour suppressor gene co-operating with the tumour suppressor Rb; an antisense or ribozyme sequence active against antagonistic kinases or cyclines; or another substance which inhibits phosphorylation of the Rb protein.
IPC 1-7
C12N 15/12; C12N 15/11; C07K 14/82; C07K 14/47; A61K 31/70; A61K 38/17
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/70 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 14/82 (2006.01); C12N 15/113 (2010.01); C12N 15/12 (2006.01); C12Q 1/68 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07K 14/4703 (2013.01); C07K 14/82 (2013.01); C12N 15/113 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01); C12N 2310/111 (2013.01)
Citation (search report)
See references of WO 9627008A2
Designated contracting state (EPC)
AT BE CH DE DK FR GB IT LI NL SE
DOCDB simple family (publication)
WO 9627008 A2 19960906; WO 9627008 A3 19961114; EP 0812355 A2 19971217; JP H10512155 A 19981124
DOCDB simple family (application)
DE 9600351 W 19960226; EP 96903923 A 19960226; JP 52595996 A 19960226